StockData

Exozymes Inc. (EXOZ) income statement

EXOZNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 5/30
$3.43+0.12 (+3.63%)

Close on Nov 18, 2026Market cap $31.84MP/E –Yield –

Exozymes Inc. income statement

Ratios

Latest available, balances at Sep 30, 2026

Profitability, FY

Gross margin
–
Operating margin
–
Net margin
–
Return on equity, FY2025
-132.6%

Financial strength

Current ratio
2.30
Debt to equity
–
Debt to assets
–
Cash to current liabilities
192.1%

Valuation

P/E ratio
–
Price to sales
–
Price to book
14.53
Dividend yield
–

See a number that looks wrong?